RESUMEN
Background: Over decades the treatment of acute pancreatitis remains debatable with no common consensus on treatment guidelines, with some workers using octreotide infusion and some workers only relying on fluid therapy and symptomatic management. This double blinded comparative trial between omega 3 fatty acid infusion versus octreotide infusion and its response in cases of acute pancreatitis. Methods: This is a study where a double blinded randomised control trial was undertaken in proven cases of acute pancreatitis and patients were given omega 3 fatty acid infusion and octreotide infusion and the observations were documented and followed upon. 50 cases were given omega 3 fatty acid infusion and other 50 were given octreotide infusion and the clinical response, symptomatic improvement was assessed and compared using BISAP and Marshal scoring systems and lipase levels.Results: Omega 3 fatty acid infusion was found to be highly significant as compared to octreotide in cases of acute pancreatitis in terms of clinical improvement, reduced hospital stay, and SIRS.Conclusions: Omega 3 fatty acid infusion is the future in cases of acute pancreatitis which is cheap and easily available with no side effects and reduces the morbidity and mortality in acute pancreatitis with reduced hospital stay in turn resulting in overall reduced medical expenditure.
RESUMEN
The biological activitites of Dikamaliartane-A, a cycloartane isolated from gum resin Dikamali of Gardenia gummifera/Gardenia lucida was screened for some pharmacological actions. The study was carried out using albino mice (20-25gr). It reduced locomotor activity and potentiated pentobarbitone-induced sleeping time in mice indicating Central Nervous System depressant activity. It protected mice from strychnine and electro shock–induced convulsions indicating that it has anti-convulsant activity. All these activities were statistically significant. The LD50 (Lethal Dose) was carried out in mice according to Organization for Environmental Cooperation and Development (OECD) Guidelines 423. The LD50 was tested in three mices for each dose with doses from 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg. The LD50 was found to be 500mg/kg.